These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells. Shen T; Yang L; Zhang Z; Yu J; Dai L; Gao M; Shang Z; Niu Y Dis Markers; 2019; 2019():4863182. PubMed ID: 31093305 [TBL] [Abstract][Full Text] [Related]
3. Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo. Zhou Q; Yu J; Zheng Q; Wu T; Ji Z; Zhuo Y FEBS Open Bio; 2021 May; 11(5):1487-1496. PubMed ID: 31774623 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms. Zeng S; Liu A; Dai L; Yu X; Zhang Z; Xiong Q; Yang J; Liu F; Xu J; Xue Y; Sun Y; Xu C BMC Cancer; 2019 Jun; 19(1):604. PubMed ID: 31216997 [TBL] [Abstract][Full Text] [Related]
5. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1. Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637 [TBL] [Abstract][Full Text] [Related]
6. miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer. Zhang L; Xu J; Yang G; Li H; Guo X Oncol Res; 2018 Jul; 26(6):949-957. PubMed ID: 29298735 [TBL] [Abstract][Full Text] [Related]
7. CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer. Zhang XG; Zhang T; Li CY; Zhang MH; Chen FM Cancer Med; 2018 Aug; 7(8):3763-3772. PubMed ID: 30022623 [TBL] [Abstract][Full Text] [Related]
8. KIF22 promotes bladder cancer progression by activating the expression of CDCA3. Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053 [TBL] [Abstract][Full Text] [Related]
9. ppGalNAc T1 as a potential novel marker for human bladder cancer. Ding MX; Wang HF; Wang JS; Zhan H; Zuo YG; Yang DL; Liu JY; Wang W; Ke CX; Yan RP Asian Pac J Cancer Prev; 2012; 13(11):5653-7. PubMed ID: 23317233 [TBL] [Abstract][Full Text] [Related]
10. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma. Du P; Wang S; Tang X; An C; Yang Y; Jiang WG Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745 [TBL] [Abstract][Full Text] [Related]
11. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer. Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis. Luo HB; Li B; Yuan WG; Xu CR J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630 [TBL] [Abstract][Full Text] [Related]
13. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer. Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099 [TBL] [Abstract][Full Text] [Related]
14. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate. Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer. Lin T; Zhou S; Gao H; Li Y; Sun L Technol Cancer Res Treat; 2018 Jan; 17():1533033818790536. PubMed ID: 30176759 [TBL] [Abstract][Full Text] [Related]
16. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells. Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer. Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984 [TBL] [Abstract][Full Text] [Related]
19. SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors. Yin H; Qin C; Zhao Y; Du Y; Sheng Z; Wang Q; Song Q; Chen L; Liu C; Xu T Clin Transl Oncol; 2017 Aug; 19(8):1035-1044. PubMed ID: 28258492 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of KNTC1 Inhibits the Proliferation, Migration and Tumorigenesis of Human Bladder Cancer Cells and Induces Apoptosis. Huang H; Fan X; Qiao Y; Yang M; Ji Z Crit Rev Eukaryot Gene Expr; 2021; 31(1):49-60. PubMed ID: 33639055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]